TotalEnergies' Business Update Reflected Continued Cash Flow Growth, RBC Says
MT newswire2026/09/29 15:55Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
11:55 AM EDT, 09/29/2026 (MT Newswires) -- TotalEnergies' (TTE) update delivered what many had expected, continued cash flow growth driven by an increasingly diversified set of businesses, RBC Capital Markets said Tuesday in a note. The integrated power segment shifting from a drain on the dividend to be a contributor should help the company significantly reduce its breakeven over the coming years, according to the note. TotalEnergies maintained its guidance to improve upstream volumes by more than 3% through 2030, but the company continues to look for new resources to supplement its portfolio post 2030, increasing its capital expenditure range to facilitate this, the note added. The company plans to shift most of its liquified natural gas sales to be Brent-linked in the coming years, effectively taking a view that US gas prices will remain cheap relative to oil prices, the brokerage said. TotalEnergies expects to degear well in excess of prior plans, supported by a strong a macro and despite higher distributions, the brokerage added. RBC made small changes to its estimates, adjusting for the mix of distributions in 2026 and raising its 2027 distribution estimates. RBC has an outperform rating on TotalEnergies with a price target of 85 euros ($96.3). Price: 88.47, Change: -1.87, Percent Change: -2.07
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
智通财经•2026/10/10 06:21
JPMorgan raises AbbVie target price to $300
格隆汇•2026/10/10 05:29
Crypto prices
MoreBitcoin
BTC
$82,756.59
+0.23%
Ethereum
ETH
$2,494.15
-0.15%
Tether USDt
USDT
$0.9991
-0.00%
BNB
BNB
$748.04
+0.68%
XRP
XRP
$1.41
+0.52%
USDC
USDC
$0.9998
+0.01%
Solana
SOL
$109.89
-0.73%
TRON
TRX
$0.3306
-0.44%
Hyperliquid
HYPE
$84.27
-1.66%
Zcash
ZEC
$1,224.72
+0.36%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now